What Fueled The Previous Growth In The Cardiovascular Implants Market?
The cardiovascular implants market has seen considerable growth due to a variety of factors.
• The market size of cardiovascular implants has seen a significant increase over the past years. Expectations are such that it will rise from $26.8 billion in 2024 to $28.86 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.7%.
The growth experienced in the past can be linked to factors such as an elderly population prone to cardiovascular risks, lifestyle habits contributing to cardiovascular threats, enhanced diagnostic technologies, expanding awareness initiatives and screening programs, as well as government-led endeavors supporting cardiovascular health.
What Can Be Expected from the Cardiovascular Implants Market Size?
The cardiovascular implants market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, it is anticipated that the cardiovascular implants market will experience robust growth. The market is set to rise to a value of $36.69 billion by 2029 with a compound annual growth rate (CAGR) of 6.2%.
This growth in the expected period can be traced back to methods of personalized medicine, emphasis on minimally invasive operations, worldwide cooperation in cardiovascular studies, health policy stress on preventative interventions, and patient-centered cardiovascular care. The forecast period reveals significant trends such as development in drug-eluting stents, the emergence of next-generation heart valves, the rising incorporation of artificial intelligence (AI), attention on minimally invasive implantation methods, personalized and patient-specific implants, and the production of leadless pacemakers.
What Are the Critical Driver Fuelling The Cardiovascular Implants Market's Growth?
The increase in heart-related health issues is projected to catalyze the expansion of the cardiovascular implants market. Heart-related health issues encompass a variety of health conditions that impact the heart and blood vessels - these include coronary artery illness, heart failure, arrhythmias, and valve disorders. The rise in heart diseases, for instance, coronary artery disease and heart failure, spurs the need for cardiovascular implants such as stents and pacemakers that treat these conditions. These implants assist heart function and circulation in individuals suffering from heart failure, facilitate the heart to beat in a consistent rhythm, and monitor heart rhythm. For illustration, a report by the British Heart Foundation (BHF) published in September 2024 mentioned that approximately 7.6 million individuals in the UK are suffering from heart and circulatory diseases. By the year 2030, the UK might witness an increment of 1 million individuals living with heart and circulatory ailments, and this figure could swell by 2 million by 2040 compared to the current statistics. Consequently, the surge in heart disorders is fueling the expansion of the cardiovascular implants market. An upward trend in the elderly population is anticipated to boost growth in the cardiovascular implants market. An increase in the elderly population pertains to a demographic change marked by a growing fraction of people who are 60 years and older in a population. Cardiovascular implants offer beneficial solutions for managing and curing heart diseases common in older people, thus improving life quality, longevity, and overall health results. For example, as per the World Health Organization in October 2022, globally, by 2030, 1 out of every 6 people is projected to be 60 or older and the count of elderly people may reach 2.1 billion by 2050. Therefore, this increase in the aging population is fueling the expansion of the cardiovascular implants market.
How Is The Cardiovascular Implants Market segmented?
The cardiovascular implants market covered in this report is segmented –
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents
Pre-Book The Cardiovascular Implants Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Cardiovascular Implants Market?
Prominent organizations in the cardiovascular implants market are intensifying their efforts to integrate advanced technology and artificial intelligence (AI) to bolster their market gains and improve the quality of patient care and precision of treatment. The progression of cardiac monitoring technology pertains to constant monitoring and recording of heart activity in a patient, which aids diagnosis and treatment of heart ailments. For example, in June 2023, BIOTRONIK SE & Co. KG, a medical technology corporation based in Germany, initiated the first worldwide implementation of their BIOMONITOR IV implantable cardiac monitor (ICM). BIOMONITOR IV is a state-of-the-art ICM that fuses BIOTRONIK's SmartECG technology with AI to reduce false-positive detections by 86% while preserving 98% of genuine episodes. Along with the refined AI, BIOMONITOR IV offers many advantages for patients and healthcare providers. Its extended battery life and wireless connectivity facilitate seamless data transfer and remote monitoring, thereby reducing the frequency of in-clinic visits.
Who Are the Key Players In The Cardiovascular Implants Market?
Major companies operating in the cardiovascular implants market report are:
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation
• W. L. Gore & Associates Inc.
• Cook Medical Incorporated
• Teleflex Incorporated
• Kyoto Medical Planning Co. Ltd.
• Abiomed Inc.
• Livanova PLC
• BIOTRONIK SE & Co. KG
• CryoLife Inc.
• Endologix Inc.
• Sorin Group
• Berlin Heart GmbH
• REVA Medical LLC.
• Syncardia Systems LLC
• Elixir Medical Corporation
• Fortimedix Surgical B.V.
• AMG International GmbH
• CHF Solutions Inc.
• Proxy Biomedical Ltd.
• Calon Cardio-Technology Ltd.
• InspireMD Inc.
• Neovasc Inc.
• Shree Pacetronix Ltd.
• Vascutek Ltd (Terumo Corporation)
What Is The Most Dominant Region In The Cardiovascular Implants Market?
North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
